Abstract
Patients with prostate cancer frequently have osseous metastases which are qualitatively assessed with bone scannings. We have studied the quantitative evaluation of skeletal diseases by measuring bone mineral density (BMD) in the lumbar vertebrae and radius. Forty-four patients with prostate cancer, nine with non-prostatic urogenital cancer and 90 controls were entered in this study. Among the patients with prostate cancer, the values of BMD in the lumbar vertebrae were significantly higher in patients with osseous metastasis than in those without metastasis, whereas the values of BMD in the radius were insignificantly different. Most of the patients with high levels of BMD in the lumbar vertebrae had osseous metastatic disease with no relationship between BMD in the lumbar vertebrae and the radius. The values of BMD in the lumbar vertebrae where hot spot scans were observed were related to X-ray findings. The alterations of BMD levels in the lumbar vertebrae were quantitatively evaluable as responses to androgen deprivation therapy. Measurement of BMD is useful for the accurate diagnosis of osteosclerotic lesions. BMD measurements of the lumbar vertebrae compared with those in the radius were variable in individuals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Catalona W.J. and Scott W.W., Carcinoma of the prostate: a review, J. Urol. 119:1–8 (1978).
Jacobs S.C., Spread of prostatic cancer to bone, Urology 21:337–344 (1983).
Fukunaga M., Tomomitsu T. and Morita R., Bone mineral determination using dual energy X-ray absorptiometry (DEXA), Jpn. J. Clin. Radiol. 35:41–48 (1990).
Soloway M.S., The importance of prognostic factors in advanced prostate cancer, Cancer 66:1017–1021 (1990).
Smith P.H., Bono F.A., da Silva F.C., Debruyne F., Denis L., Robinson P., Sylvester R. and Armitage T.G., The EORTC Urological Group: Some limitation of the radioisotope bone scan in patients with metastatic prostatic cancer, Cancer 66:1009–1016 (1990).
Slack N.H., Karr J.P., Chu T.M. and Murphy G.P., Investigators in the National Prostatic Cancer Project: An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma, The Prostate 1:259–270 (1980).
Dann J., Castronovo F.P. Jr., McKusick K.A., Griffin P.P., Strauss H.M. and Prout G.R. Jr., Total bone uptake in management of metastatic carcinoma of the prostate, J. Urol. 137:444–447 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tanaka, H., Furukawa, Y., Fukunaga, K., Fukunaga, M. (1992). Bone Mineral Density for Patients with Bone Metastasis of Prostate Cancer: A Preliminary Report. In: Karr, J.P., Yamanaka, H. (eds) Prostate Cancer and Bone Metastasis. Advances in Experimental Medicine and Biology, vol 324. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3398-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3398-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6501-3
Online ISBN: 978-1-4615-3398-6
eBook Packages: Springer Book Archive